Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

NCT01210495 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Axitinib (AG-013736)
OTHER: Best Supportive Care
DRUG: Placebo
OTHER: Best Supportive Care

Sponsor

Pfizer